Nonalcoholic fatty liver disease (NAFLD) is becoming the most common cause of chronic
liver disease in the developing world, found in 17-30% of the population in Western …

Background and Aims Liver disease remains a leading cause of morbidity and mortality
among people living with HIV (PLWH). Emerging data suggest that PLWH are at high risk for …

Abstract An estimated 2%–3% of the world's population is living with hepatitis C virus (HCV)
infection, and each year,> 350 000 die of HCV-related conditions, including cirrhosis and …

Background A safe, simple, effective, and pan-genotypic regimen to treat hepatitis C virus
(HCV) infection in patients coinfected with human immunodeficiency virus type 1 (HIV-1) …

Ambient electrostatic paper spray ionization from a hydrophobic paper occurs when a DC
potential is applied to the dry paper triangle. Online liquid/liquid extraction of small organic …

Background Mycobacterium tuberculosis (TB) infection of the liver, known as hepatic TB, is
an extrapulmonary manifestation of TB. Hepatic TB has become more prevalent, likely as a …

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed
countries. Its frequency is increasing in the general population mostly due to the widespread …

The burden of liver-related morbidity remains high among HIV-infected patients, despite
advances in the treatment of HIV and viral hepatitis. Especially, the impact of non-alcoholic …

Background Twelve percent of all acute liver failure (ALF) cases are of unknown origin, often
termed indeterminate. A previously unrecognized hepatotropic virus has been suspected as …

Due to the improved effectiveness and safety of combined antiretroviral therapy, human
immunodeficiency virus (HIV) infection has become a manageable, chronic condition rather …